Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 58
Filter
2.
J Prev Alzheimers Dis ; 9(1): 67-76, 2022.
Article in English | MEDLINE | ID: mdl-35098975

ABSTRACT

Neuroimaging serves a variety of purposes in Alzheimer's disease (AD) and related dementias (ADRD) research - from measuring microscale neural activity at the subcellular level, to broad topological patterns seen across macroscale-brain networks, and everything in between. In vivo imaging provides insight into the brain's structure, function, and molecular architecture across numerous scales of resolution; allowing examination of the morphological, functional, and pathological changes that occurs in patients across different AD stages (1). AD is a complex and potentially heterogenous disease, with no proven cure and no single risk factor to isolate and measure, whilst known risk factors do not fully account for the risk of developing this disease (2). Since the 1990's, technological advancements in neuroimaging have allowed us to visualise the wide organisational structure of the brain (3) and later developments led to capturing information of brain 'functionality', as well as the visualisation and measurement of the aggregation and accumulation of AD-related pathology. Thus, in vivo brain imaging has and will continue to be an instrumental tool in clinical research, mainly in the pre-clinical disease stages, aimed at elucidating the biological complex processes and interactions underpinning the onset and progression of cognitive decline and dementia. The growing societal burden of AD/ADRD means that there has never been a greater need, nor a better time, to use such powerful and sensitive tools to aid our understanding of this undoubtedly complex disease. It is by consolidating and reflecting on these imaging advancements and developing long-term strategies across different disciplines, that we can move closer to our goal of dementia prevention. This short commentary will outline recent developments in neuroimaging in the field of AD and dementia by first describing the historical context of AD classification and the introduction of AD imaging biomarkers, followed by some examples of significant recent developments in neuroimaging methods and technologies.


Subject(s)
Alzheimer Disease , Cognitive Dysfunction , Alzheimer Disease/diagnosis , Biomarkers , Brain/diagnostic imaging , Brain/pathology , Cognitive Dysfunction/diagnostic imaging , Cognitive Dysfunction/pathology , Humans , Neuroimaging/methods
3.
Eur J Neurol ; 25(2): 307-312, 2018 02.
Article in English | MEDLINE | ID: mdl-29078029

ABSTRACT

BACKGROUND AND PURPOSE: Constipation is a common non-motor symptom of Parkinson's disease (PD). Deposition of α-synuclein inclusions that spread from the gut to the substantia nigra through the vagus nerve has recently been speculated to be a pre-motor and early stage of PD. The aim of the study was to investigate whether constipation is associated with dopaminergic pathology on dopamine transporter (DAT) single-photon emission computed tomography in early drug-naïve patients with PD. Our hypothesis was that constipation is associated with other signs of pre-motor PD and is independent of DAT pathology. We then investigated for associations with motor and non-motor symptoms, and with cerebrospinal fluid biomarkers of PD pathology. METHODS: Using the Parkinson's Progression Markers Initiative database, we investigated the prevalence of constipation and the association between constipation and clinical features, striatal [123 I]Ioflupane uptake and non-imaging (cerebrospinal fluid and serum) biomarkers. Constipation was evaluated using Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part I item 1.11. RESULTS: One third (132/398) of de-novo patients with PD had constipation. Higher severity of constipation correlated with older age (r = 0.728, P < 0.001), higher MDS-UPDRS total score (r = 0.285, P < 0.001), worse postural instability (r = 0.190, P = 0.012), rapid eye movement sleep behaviour disorder (r = 0.228, P < 0.0001) and depression (r = 0.187, P = 0.024). No correlation was found with cerebrospinal fluid, serum and imaging markers of PD pathology. CONCLUSIONS: Constipation was not associated with DAT pathology but with rapid eye movement sleep behaviour disorder and depression, which are speculated to be pre-motor symptoms of PD. This confirms the hypothesis that constipation may be a pre-motor sign of PD due to an impairment of non-dopaminergic pathways.


Subject(s)
Constipation , Depression , Dopamine Plasma Membrane Transport Proteins/metabolism , Parkinson Disease , REM Sleep Behavior Disorder , Aged , Constipation/epidemiology , Constipation/etiology , Constipation/physiopathology , Depression/epidemiology , Depression/etiology , Depression/physiopathology , Female , Humans , Iodine Radioisotopes , Male , Middle Aged , Parkinson Disease/complications , Parkinson Disease/epidemiology , Parkinson Disease/metabolism , Parkinson Disease/physiopathology , Prevalence , REM Sleep Behavior Disorder/epidemiology , REM Sleep Behavior Disorder/etiology , REM Sleep Behavior Disorder/physiopathology , Radiopharmaceuticals , Severity of Illness Index , Tomography, Emission-Computed, Single-Photon
4.
Eur J Neurol ; 24(9): 1173-1182, 2017 09.
Article in English | MEDLINE | ID: mdl-28752644

ABSTRACT

BACKGROUND AND PURPOSE: A growing body of evidence suggests that cardiovascular disease risk factors including hypertension may be linked to sporadic Alzheimer's disease (AD). It is well known that hypertension is associated with cerebrovascular disease and vascular dementia on the basis of vascular remodeling. However, the mechanisms linking hypertension and AD remain unclear. METHODS: We studied 197 patients with AD (86 male; mean age ± SD: 75.8 ± 7.4 years) from the Alzheimer's Disease Neuroimaging Initiative database with (n = 97) and without (n = 100) hypertension. We explored associations between hypertension and clinical, plasma, cerebrospinal fluid and imaging markers of AD pathology in order to elucidate the underlying mechanisms that may link AD and hypertension. RESULTS: We found that patients with AD with hypertension had worse cognitive function (Alzheimer's disease Assessment Scale-cognitive subscale, P = 0.038) and higher neuropsychiatric symptom burden (Neuropsychiatric Inventory Questionnaire, P = 0.016) compared with those without hypertension. Patients with AD with hypertension showed reduced glucose hypometabolism in the right (P < 0.001) and left (P = 0.007) hippocampus. No differences were found in magnetic resonance imaging volumetric measurements, [18 F]florbetapir uptakes, plasma and cerebrospinal fluid between patients with AD with and without hypertension. CONCLUSIONS: Although hypertension is associated with worse cognitive function, behavioural symptoms and hippocampal glucose hypometabolism, it is not associated with evidence of increased amyloid or tau pathology. Effective management of hypertension may potentially have a therapeutic role in the alleviation of symptoms in AD.


Subject(s)
Alzheimer Disease/complications , Alzheimer Disease/psychology , Cognition Disorders/etiology , Cognition Disorders/psychology , Hippocampus/metabolism , Hypertension/complications , Hypertension/psychology , Aged , Aged, 80 and over , Alzheimer Disease/metabolism , Aniline Compounds/blood , Aniline Compounds/cerebrospinal fluid , Cognition , Cognition Disorders/metabolism , Cost of Illness , Ethylene Glycols/blood , Ethylene Glycols/cerebrospinal fluid , Female , Glucose/metabolism , Humans , Hypertension/metabolism , Magnetic Resonance Imaging , Male , Middle Aged , Neuroimaging , Neuropsychological Tests , Positron-Emission Tomography , Psychiatric Status Rating Scales , Radiopharmaceuticals/blood , Radiopharmaceuticals/cerebrospinal fluid
5.
NPJ Parkinsons Dis ; 3: 5, 2017.
Article in English | MEDLINE | ID: mdl-28649605

ABSTRACT

Parkinson's disease (PD) is now considered to be a multisystemic disorder consequent on multineuropeptide dysfunction including dopaminergic, serotonergic, cholinergic, and noradrenergic systems. This multipeptide dysfunction leads to expression of a range of non-motor symptoms now known to be integral to the concept of PD and preceding the diagnosis of motor PD. Some non-motor symptoms in PD may have a dopaminergic basis and in this review, we investigate the evidence for this based on imaging techniques using dopamine-based radioligands. To discuss non-motor symptoms we follow the classification as outlined by the validated PD non-motor symptoms scale.

6.
Eur J Neurol ; 24(2): 357-365, 2017 02.
Article in English | MEDLINE | ID: mdl-27982501

ABSTRACT

BACKGROUND AND PURPOSE: To determine whether iron deposition in deep brain nuclei assessed using high-pass filtered phase imaging plays a role in motor disease severity in Parkinson's disease (PD). METHODS: Seventy patients with mild to moderate PD and 20 age- and gender-matched healthy volunteers (HVs) underwent susceptibility-weighted imaging on a 3 T magnetic resonance imaging scanner. Phase shifts (radians) in deep brain nuclei were derived from high-pass filtered phase images and compared between groups. Analysis of clinical laterality and correlations with motor severity (Unified Parkinson's Disease Rating Scale, Part III, UPDRS-III) were performed. Phase shifts (in radians) were compared between HVs and three PD subgroups divided according to UPDRS-III scores using analysis of covariance, adjusting for age and regional area. RESULTS: Parkinson's disease patients had significantly (P < 0.001) higher radians than HVs bilaterally in the putamen, globus pallidus and substantia nigra (SN). The SN contralateral to the most affected side showed higher radians (P < 0.001) compared to the less affected side. SN radians positively correlated with UPDRS-III and bradykinesia-rigidity subscores, but not with tremor subscores. ancova followed by post hoc Bonferroni-adjusted pairwise comparisons revealed that SN radians were significantly greater in the PD subgroup with higher UPDRS-III scores compared to both lowest UPDRS-III PD and HV groups (P < 0.001). CONCLUSIONS: Increased nigral iron accumulation in PD appears to be stratified according to disease motor severity and correlates with symptoms related to dopaminergic neurodegeneration. This semi-quantitative in vivo iron assessment could prove useful for objectively monitoring PD progression, especially in clinical trials concerning iron chelation therapies.


Subject(s)
Gray Matter/metabolism , Iron/metabolism , Movement Disorders/physiopathology , Parkinson Disease/metabolism , Parkinson Disease/physiopathology , Adult , Aged , Cross-Sectional Studies , Disease Susceptibility , Female , Gray Matter/diagnostic imaging , Humans , Hypokinesia/etiology , Hypokinesia/physiopathology , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Male , Middle Aged , Movement Disorders/etiology , Muscle Rigidity/etiology , Muscle Rigidity/physiopathology , Parkinson Disease/complications , Parkinson Disease/diagnostic imaging , Substantia Nigra/diagnostic imaging , Substantia Nigra/metabolism
7.
Int J Obes (Lond) ; 40(7): 1051-5, 2016 07.
Article in English | MEDLINE | ID: mdl-27113488

ABSTRACT

INTRODUCTION: Younger children, non-Hispanic Black and male children who are overweight (body mass index (BMI) ⩾85th percentile) are at greater risk for being misperceived by their parents as having a healthy or normal weight, but less is known about the risk for weight misperception in the subpopulation of children with obesity (BMI⩾95th percentile). We assessed the gender, age and racial/ethnic differences in parental misperception of healthy or normal weight status in children with obesity. METHODS: We analyzed the data of 1445 children and adolescents aged 6-15 years with obesity obtained from the National Health and Nutrition Examination Surveys conducted from 2005 to 2012. Parental perception of the child's weight was obtained during an in-home interview. Anthropometric data on body weight were collected from the children during their physical and used to calculate gender and age-specific BMI percentiles. Logistic regression was used to calculate the adjusted odds ratios for parental misperception of their child's obesity as being 'about the right weight', using parents who perceived their children with obesity as being 'overweight' for reference. RESULTS: Boys aged 6-15 years with obesity were more likely to be misperceived as being 'about the right weight' by their parents (adjusted odds ratio (aOR): 1.40 (1.12-1.76) vs girls, P=0.0038). The subpopulations of children with obesity who were significantly less likely to be misperceived included girls aged 11-15 years (aOR: 0.46 (0.29-0.74) vs girls 6-10 years, P=0.0016) and Hispanic males (aOR: 0.58 (0.36-0.93) vs White males, P=0.02). CONCLUSIONS: Significant age differences in the odds for parental misclassification of obesity as 'about the right weight' were detected in female children, but not males. Hispanic males with obesity were significantly less likely to be misperceived as being 'about the right weight' when compared with their non-Hispanic White peers.


Subject(s)
Body Weight , Ethnicity/psychology , Parents/psychology , Pediatric Obesity/epidemiology , Pediatric Obesity/psychology , Racial Groups/psychology , Adolescent , Age Factors , Body Mass Index , Child , Child Nutritional Physiological Phenomena , Female , Guidelines as Topic , Health Knowledge, Attitudes, Practice , Humans , Logistic Models , Male , Nutrition Surveys , Odds Ratio , Parents/education , Pediatric Obesity/prevention & control , Sex Factors , United States/epidemiology
8.
J Mol Model ; 20(5): 2221, 2014 May.
Article in English | MEDLINE | ID: mdl-24810462

ABSTRACT

Modeling proton-induced damage in biological systems, in particular in DNA building blocks, is of major concern in studies on cancer proton therapy. This is indeed an extremely complex process and analysis of the mechanism at the molecular level is of crucial interest. Such collision reactions of protons on biological targets induce different reactions: excitation and ionization of the biomolecule, fragmentation of the ionized species, and charge transfer from the projectile ion toward the biomolecular target. In order to have an insight into such mechanisms, we have performed a theoretical approach of two of the most important steps, the fragmentation and the charge transfer processes. For that purpose, we have considered collision of protons with isolated 2-deoxy-D-ribose by means of ab-initio molecular dynamics and quantum chemistry molecular methods. The conformation of the sugar moiety has been analyzed and appears to induce important effects, in particular different fragmentation patterns have been pointed out with regard to the conformation, and significant variations of the charge transfer cross sections have been exhibited.


Subject(s)
DNA Damage , Deoxyribose/chemistry , Models, Chemical , Models, Molecular , Molecular Dynamics Simulation , Protons , Carbohydrate Conformation , Energy Transfer , Nucleic Acid Conformation , Quantum Theory , Structure-Activity Relationship
9.
Eur J Neurol ; 21(5): 694-9, e39-43, 2014 May.
Article in English | MEDLINE | ID: mdl-24471508

ABSTRACT

Levodopa-induced dyskinesias (LIDs) and graft-induced dyskinesias (GIDs) are serious and common complications of Parkinson's disease (PD) management following chronic treatment with levodopa or intrastriatal transplantation with dopamine-rich foetal ventral mesencephalic tissue, respectively. Positron emission tomography (PET) molecular imaging provides a powerful in vivo tool that has been employed over the past 20 years for the elucidation of mechanisms underlying the development of LIDs and GIDs in PD patients. PET used together with radioligands tagging molecular targets has allowed the functional investigation of several systems in the brain including the dopaminergic, serotonergic, glutamatergic, opioid, endocannabinoid, noradrenergic and cholinergic systems. In this article the role of PET imaging in unveiling pathophysiological mechanisms underlying the development of LIDs and GIDs in PD patients is reviewed.


Subject(s)
Dyskinesia, Drug-Induced/diagnostic imaging , Dyskinesia, Drug-Induced/etiology , Positron-Emission Tomography , Antiparkinson Agents/adverse effects , Fluorodeoxyglucose F18 , Humans , Levodopa/adverse effects , Parkinson Disease/drug therapy
10.
Brain Res ; 1461: 111-8, 2012 Jun 21.
Article in English | MEDLINE | ID: mdl-22608068

ABSTRACT

Buspirone is an anxiolytic drug and is a partial agonist for the serotonin 5-HT(1A) receptors as well as possessing low affinity and is an antagonist for the dopamine D(2) autoreceptors, with some evidence of a weak affinity to 5-HT(2) receptors. The underlying mechanism of action of buspirone is not clear; however it is thought that its main pharmacology is mediated via the 5-HT(1A) receptors. Initially developed for use in the treatment of generalised anxiety disorder, it appears that buspirone may be useful in various other neurological and psychiatric disorders, such as attenuating side effects of Parkinson's disease therapy, ataxia, depression, social phobia, and behaviour disturbances following brain injury, and those accompanying Alzheimer's disease, dementia and attention deficit disorder. Considering the potential of this drug to be included in the management of many conditions, thorough and controlled studies are required to elucidate the exact mechanism of action. This review will consider the evidence so far for both the potential underlying mechanisms and its use in various conditions.


Subject(s)
Buspirone/pharmacokinetics , Buspirone/therapeutic use , Dopamine D2 Receptor Antagonists , Serotonin 5-HT1 Receptor Agonists/pharmacokinetics , Serotonin 5-HT1 Receptor Agonists/therapeutic use , Animals , Dyskinesia, Drug-Induced/drug therapy , Dyskinesia, Drug-Induced/metabolism , Humans , Mental Disorders/drug therapy , Mental Disorders/metabolism , Motor Activity/drug effects , Motor Activity/physiology , Receptors, Dopamine D2/metabolism
11.
Phys Rev Lett ; 107(2): 023202, 2011 Jul 08.
Article in English | MEDLINE | ID: mdl-21797602

ABSTRACT

A combination of time-dependent density functional theory and Born-Oppenheimer molecular dynamics methods is used to investigate fragmentation of doubly charged gas-phase uracil in collisions with 100 keV protons. The results are in good agreement with ion-ion coincidence measurements. Orbitals of similar energy and/or localized in similar bonds lead to very different fragmentation patterns, thus showing the importance of intramolecular chemical environment. In general, the observed fragments do not correspond to the energetically most favorable dissociation path, which is due to dynamical effects occurring in the first few femtoseconds after electron removal.


Subject(s)
Electrons , Gases/chemistry , Molecular Dynamics Simulation , Uracil/chemistry , Kinetics , Molecular Conformation , Spectrum Analysis
12.
Eur J Neurol ; 18(2): 226-231, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20636368

ABSTRACT

BACKGROUND: Multiple Sclerosis (MS) is traditionally considered as a central nervous system (CNS) white matter inflammatory disease. However, recent studies have focused on the neurodegenerative aspects of the disease, which occur early in the pathological process, providing an opportunity for therapeutic intervention and application of neuroprotective strategies. The relationship between neural inflammation and cell death remains controversial. The recent development of new radiolabelled ligands provides positron emission tomography (PET) imaging with a role for studying early aspects of the MS pathology. METHODS: We provide an overview of current PET research in MS, particularly focussing on possible applications of new radioligands for studying inflammation and neurodegenerative processes. RESULTS: Pathological aspects of neuroinflammation, axonal degeneration and neuronal repair may be explored in vivo with selective PET tracers. Specific radioligands for the cannabinoid system may be applied in MS research to understand the role of this neurotransmitter system in the pathogenesis of the disease. CONCLUSIONS: PET imaging represents a promising tool for elucidating controversial aspects of MS pathology and for the assessment of selective and potentially neuroprotective therapies.


Subject(s)
Multiple Sclerosis/diagnostic imaging , Positron-Emission Tomography , Radiopharmaceuticals , Apoptosis , Cannabinoids/metabolism , Humans , Inflammation/diagnostic imaging , Multiple Sclerosis/metabolism , Multiple Sclerosis/pathology
13.
Neurology ; 75(21): 1920-7, 2010 Nov 23.
Article in English | MEDLINE | ID: mdl-21098407

ABSTRACT

BACKGROUND: Depression associated with Parkinson disease (PD) has a different symptom profile to endogenous depression. The etiology of depression in PD remains uncertain though abnormal serotonergic neurotransmission could play a role. OBJECTIVE: To assess with PET serotonergic function via in vivo serotonin transporter (5-HTT) availability in antidepressant-naive patients with PD. METHODS: Thirty-four patients with PD and 10 healthy matched control subjects had a clinical battery of tests including the patient-report Beck Depression Inventory-II (BDI-II), the clinician-report Hamilton Rating Scale for Depression (HRSD), and the structured clinical interview for DSM-IV Axis I Disorders (SCID-I). They underwent ¹¹C-DASB PET, a selective in vivo marker of 5-HTT binding in humans. RESULTS: BDI-II scores correlated with HRSD scores. Ten of 34 patients with PD (29.4%) had BDI-II and HRSD scores above the discriminative cutoff for PD depression though only half of these patients could be classed on SCID-I criteria as having an anxiety/mood disorder. Patients with PD with the highest scores for depression symptoms showed significantly raised ¹¹C-DASB binding in amygdala, hypothalamus, caudal raphe nuclei, and posterior cingulate cortex compared to low score cases, while ¹¹C-DASB binding values in other regions were similarly decreased in depressed and nondepressed patients with PD compared to healthy controls. CONCLUSION: Depressive symptoms in antidepressant-naive patients with PD correlate with relatively higher 5-HTT binding in raphe nuclei and limbic structures possibly reflecting lower extracellular serotonin levels. Our data are compatible with a key role of abnormal serotonergic neurotransmission contributing to the pathophysiology of PD depression and justify the use of agents acting on 5-HTT.


Subject(s)
Depression/etiology , Limbic System/metabolism , Parkinson Disease/psychology , Raphe Nuclei/metabolism , Serotonin Plasma Membrane Transport Proteins/metabolism , Benzylamines , Carbon Radioisotopes , Depression/diagnosis , Humans , Positron-Emission Tomography , Psychiatric Status Rating Scales , Tissue Distribution , Up-Regulation
14.
Mutat Res ; 704(1-3): 45-53, 2010.
Article in English | MEDLINE | ID: mdl-20079878

ABSTRACT

Theoretical simulations are particularly well suited to investigate, at a molecular level, direct and indirect effects of ionising radiations in DNA, as in the particular case of irradiation by swift heavy ions such as those used in hadron therapy. In the past recent years, we have developed the modeling at the microscopic level of the early stages of the Coulomb explosion of DNA molecules immersed in liquid water that follows the irradiation by swift heavy ions. To that end, Time-Dependent Density Functional Theory molecular dynamics simulations (TD-DFT MD) have been developed where localised Wannier orbitals are propagated. This latter enables to separate molecular orbitals of each water molecule from the molecular orbitals of the biomolecule. Our main objective is to demonstrate that the double ionisation of one molecule of the liquid sample, either one water molecule from the solvent or the biomolecule, may be in some cases responsible for the formation of an atomic oxygen as a direct consequence of the molecule Coulomb explosion. Our hypothesis is that the molecular double ionisation arising from irradiation by swift heavy ions (about 10% of ionisation events by ions whose velocity is about the third of speed of light), as a primary event, though maybe less probable than other events resulting from the electronic cascading (for instance, electronic excitations, electron attachments), may be systematically more damageable (and more lethal), as supported by experiments that have been carried out in our group in the 1990s (in studies of damages created by K holes in DNA). The chemical reactivity of the produced atomic oxygen with other radicals present in the medium will ultimately lead to chemical products that are harmful to DNA. In the present paper, we review our theoretical methodology in an attempt that the community be familiar with our new approach. Results on the production of atomic oxygen as a result of the double ionisation of water or as a result of the double ionisation of the Uracil RNA base will be presented.


Subject(s)
DNA Damage , Models, Theoretical , Radiation, Ionizing , Water/chemistry , Computational Biology , Heavy Ions , Immersion , Molecular Dynamics Simulation , Oxygen/chemistry , Uracil/chemistry
16.
Postgrad Med J ; 85(1009): 590-6, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19892894

ABSTRACT

Impulse control disorders (ICDs) are a heterogeneous group of conditions involving repetitive, excessive and compulsive activities that interfere with life functioning. Examples are pathological gambling, compulsive shopping and hypersexuality. Over the last decade, ICDs have become increasingly recognised as being associated with Parkinson disease (PD), with the literature highlighting a link between dopamine replacement therapy and the development of ICDs. Patients who develop ICDs in the context of compulsive anti-Parkinsonian drug use are described as having dopamine dysregulation syndrome (DDS), which is associated with repetitive complex stereotyped behaviours called punding. Case-control and observational studies have further noted that patients with PD who develop ICDs are more likely to have younger-onset PD, a history of alcohol dependence, novelty-seeking personality traits and psychiatric comorbidities. The pathophysiology of underlying mechanisms is not fully understood, but recent evidence suggests that dopaminergic drugs, particularly dopamine agonists, coupled with changes in reward pathways involving the ventral striatal and related circuitry, may play a role. Neuroimaging studies using positron emission tomography and functional MRI have provided valuable information in this area: patients with DDS have been found to show enhanced dopamine release in the ventral striatum, suggesting functional abnormalities in the mesolimbic networks. Management of ICDs in patients with PD can be challenging, as they may not be aware of a change in their behaviour or may conceal their symptoms to avoid embarrassment. Currently, there is no clear evidence of an optimal treatment. Management is based on a careful balance of dopaminergic drugs with control of the aberrant behaviour, supported by psychological interventions. This review aims to summarise the current literature on ICDs, their phenomenology, epidemiology, clinical features, pathophysiology and management.


Subject(s)
Disruptive, Impulse Control, and Conduct Disorders/etiology , Parkinson Disease/psychology , Deep Brain Stimulation/methods , Diagnosis, Differential , Diagnostic Imaging , Disruptive, Impulse Control, and Conduct Disorders/diagnosis , Disruptive, Impulse Control, and Conduct Disorders/therapy , Dopamine Agents/adverse effects , Dopamine Agonists/therapeutic use , Humans , Patient Education as Topic
17.
Phys Rev Lett ; 100(18): 183401, 2008 May 09.
Article in English | MEDLINE | ID: mdl-18518369

ABSTRACT

We have determined absolute charge transfer and fragmentation cross sections in He2++C60 collisions in the impact-energy range 0.1-250 keV by using a combined experimental and theoretical approach. We have found that the cross sections for the formation of He+ and He0 are comparable in magnitude, which cannot be explained by the sole contribution of pure single and double electron capture but also by contribution of transfer-ionization processes that are important even at low impact energies. The results show that multifragmentation is important only at impact energies larger than 40 keV; at lower energies, sequential C2 evaporation is the dominant process.

18.
Int J Radiat Biol ; 83(10): 687-97, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17729163

ABSTRACT

PURPOSE: To study the effect of hydration level and plasmid packing on strand break induction in DNA by ultrasoft X-ray. MATERIALS AND METHODS: Bluescript (pBS, tight packing) and pSP189 (pSP, loose packing) plasmids were irradiated by 250, 380, and 760 eV ultrasoft X-rays at the Laboratoire pour l'Utilisation du Rayonnement Electromagnétique synchrotron facility (Orsay, France). Single and double strand breaks (SSB and DSB) were quantified by gel electrophoresis. RESULTS: The number of DSB per Gray and per Dalton in pBS plasmids were (5.6 +/- 0.1), (6.3 +/- 0.1) and (8.5 +/- 0.4)x10(-12) at 250, 380 and 760 eV, respectively. They were respectively 1.4 +/- 0.1, 1.1 +/- 0.1 and 1.9 +/- 0.2 times larger for pSP plasmids. SSB/DSB ratios varied between 4.4 and 6.4. CONCLUSION: The observed dependency of strand break induction by ultrasoft X-rays on the hydration level of DNA in plasmids films may be associated with: (i) Damage transfer from the water shell to the DNA and/or (ii) change in packing. 760 eV photons which are more often absorbed in the hydration shell and yield longer range electrons than 250 and 380 eV photons, induce more DSB per Gray and per Dalton, especially for the looser plasmid (pSP).


Subject(s)
DNA Damage/radiation effects , DNA, Single-Stranded/radiation effects , Plasmids/radiation effects , Water/chemistry , X-Rays , Dose-Response Relationship, Radiation , Electrophoresis, Gel, Two-Dimensional/methods , Photons
19.
Radiat Res ; 163(2): 222-31, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15658899

ABSTRACT

TILDA, a new Monte Carlo track structure code for ions in gaseous water that is valid for both high-LET (approximately 10(4) keV/microm) and low-LET ions, is presented. It is specially designed for a comparison of the patterns of energy deposited by a large range of ions. Low-LET ions are described in a perturbative frame, whereas heavy ions with a very high stopping power are treated using the Lindhard local density approximation and the Russek and Meli statistical method. Ionization cross sections singly differential with energy compare well with the experiment. As an illustration of the non-perturbative interaction of high-LET ions, a comparison between the ion tracks of light and heavy ions with the same specific energy is presented (1.4 MeV/nucleon helium and uranium ions). The mean energy for ejected electrons was found to be approximately four times larger for uranium than for helium, leading to a much larger track radius in the first case. For electrons, except for the excitation cross sections that are deduced from experimental fits, cross sections are derived analytically. For any orientation of the target molecule, the code calculates multiple differential cross sections as a function of the ejection and scattering angles and of the energy transfer. The corresponding singly differential and total ionization cross sections are in good agreement with experimental data. The angular distribution of secondary electrons is shown to depend strongly on the orientation of the water molecule.


Subject(s)
Algorithms , Heavy Ions , Linear Energy Transfer , Models, Chemical , Radiometry/methods , Software , Water/chemistry , Computer Simulation , Models, Statistical , Monte Carlo Method , Radiation Dosage
20.
Int J Radiat Biol ; 80(2): 135-45, 2004 Feb.
Article in English | MEDLINE | ID: mdl-15164795

ABSTRACT

PURPOSE: To study the frequency of chromosome aberrations induced by soft X-rays. To see if the core ionization of DNA atoms is involved in this end-point as much as it appears to be in cell killing. MATERIALS AND METHODS: V79 hamster cells were irradiated by synchrotron radiation photons iso-attenuated in the cell (250, 350, 810eV). The morphological chromosome aberrations detected in the first post-irradiation cell division (dicentrics and centric rings) were studied by Giemsa staining. RESULTS: The chromosome aberrations at 350eV were, respectively, 2.6 +/- 0.8 and 2.1 +/- 0.8 times more numerous than at 250 and 810eV for the same average dose absorbed by the nucleus. These relative effectivenesses are comparable with the ones already measured for cell killing. Moreover, they roughly vary such as the relative numbers of core ionizations (including in the phosphorus L-shell) produced in DNA and its bound water (water being involved only at 810eV through the oxygen atoms). In particular, they reproduce the characteristic twofold enhancement at 350eV, above the carbon K threshold. CONCLUSIONS: Correlations suggest that the core ionization process is likely a common and essential mechanism initiating both chromosome aberration and cell killing end-points at these photon energies.


Subject(s)
Chromosome Aberrations , DNA/radiation effects , X-Rays , Animals , Carbon/chemistry , Cell Division , Cell Line , Cell Nucleus/metabolism , Cricetinae , Dose-Response Relationship, Radiation , Gamma Rays , Ions , Oxygen/metabolism , Photons , Radiation, Ionizing , Radiometry
SELECTION OF CITATIONS
SEARCH DETAIL
...